Provision of smoking cessation therapy

被引：0
作者：
Perriot, J [1 ]
机构：
[1] Dispensaire Emile Roux, F-63100 Clermont Ferrand, France
来源：
REVUE DES MALADIES RESPIRATOIRES | 2006年 / 23卷
关键词：
smoking cessation; tobacco addiction; motivation; follow up; depressive disorders;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Introduction Smoking cessation therapies help well motivated smokers give up and increase the chance of success. Background Medical, behavioural and cognitive cessation therapies are aimed at relieving the secondary effects of stopping smoking : withdrawal symptoms and the urgent need to smoke. A prolonged follow up helps to prevent relapse. Viewpoint The education of doctors and the development of new drugs should increase the rate of successful withdrawal. Conclusion All doctors, particularly respiratory physicians, should be involved in smoking cessation. The aim of this practical guide is to help them in everyday practice.
引用
收藏
页码：S85 / S105
页数：21
相关论文
共 93 条
  • [11] Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation
    Berlin, I
    Aubin, HJ
    Pedarriosse, AM
    Rames, A
    Lancrenon, S
    Lagrue, G
    [J]. ADDICTION, 2002, 97 (10) : 1347 - 1354
  • [12] BERLIN I, 2003, COURR ADD, V5, P112
  • [13] Berlin JD, 2002, ONCOLOGY-NY, V16, P13
  • [14] Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation -: A randomized, double-blind, placebo-controlled trial
    Bohadana, A
    Nilsson, F
    Rasmussen, T
    Martinet, Y
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) : 3128 - 3134
  • [15] Bolliger Chris T, 2002, Nicotine Tob Res, V4, P433, DOI 10.1080/1462220021000018380
  • [16] Smoking reduction with oral nicotine inhalers:: double blind, randomised clinical trial of efficacy and safety
    Bolliger, CT
    Zellweger, JP
    Danielsson, T
    van Biljon, X
    Robidou, A
    Westin, Å
    Perruchoud, AP
    Säwe, U
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7257): : 329 - 333
  • [17] BORGNE A, 2002, LETT PHARM, V16, P23
  • [18] Borgne Anne, 2004, Rev Prat, V54, P1883
  • [19] BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P1069
  • [20] Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
    Coe, JW
    Brooks, PR
    Vetelino, MG
    Wirtz, MC
    Arnold, EP
    Huang, JH
    Sands, SB
    Davis, TI
    Lebel, LA
    Fox, CB
    Shrikhande, A
    Heym, JH
    Schaeffer, E
    Rollema, H
    Lu, Y
    Mansbach, RS
    Chambers, LK
    Rovetti, CC
    Schulz, DW
    Tingley, FD
    O'Neill, BT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3474 - 3477
12345678910